16
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Complement Activation and the Production of Inflammatory Mediators During the Treatment of Severe Sepsis in Humans

, , , , , , , & show all
Pages 197-204 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

G.U. Meduri. (1999) New Rationale for Glucocorticoid Treatment in Septic Shock. Journal of Chemotherapy 11:6, pages 541-550.
Read now
Gere Sunder-Plassmann & Walter H. Hörl. (1996) Can Hemodialysis Technique Modify the Hypercatabolic State?. Renal Failure 18:3, pages 395-404.
Read now

Articles from other publishers (24)

Tzu Hsuan Cheng, Michael Puskarich, Xiang Li, Zhou Fang, Fou Xu, Yong Chen, Xian-Cheng Jiang, Samrat Worah, Alan E. Jones & Ming Zhang. (2020) Circulating Complement C3-Alpha Chain Levels Predict Survival of Septic Shock Patients. Shock 54:2, pages 190-197.
Crossref
Tom E. Mollnes & Markus Huber‐Lang. (2020) Complement in sepsis—when science meets clinics. FEBS Letters 594:16, pages 2621-2632.
Crossref
Günseli Orhun, Figen Esen, Perihan Ergin Özcan, Serra Sencer, Başar Bilgiç, Canan Ulusoy, Handan Noyan, Melike Küçükerden, Achmet Ali, Mehmet Barburoğlu & Erdem Tüzün. (2018) Neuroimaging Findings in Sepsis-Induced Brain Dysfunction: Association with Clinical and Laboratory Findings. Neurocritical Care 30:1, pages 106-117.
Crossref
Dajana Lendak, Dunja Mihajlovic, Gorana Mitic, Milan Ubavic, Aleksandra Novakov-Mikic, Jasmina Boban & Snežana Brkic. (2018) Complement component consumption in sepsis correlates better with hemostatic system parameters than with inflammatory biomarkers. Thrombosis Research 170, pages 126-132.
Crossref
Syamal Modi, Mohd Rashid, Abida Malik & Mohd Shahid. (2013) COMPLEMENT ACTIVATION, C3 AND INTERLEUKIN-6 LEVELS AS PROGNOSTIC MARKERS IN POLYTRAUMATIZED PATIENTS. Journal of Evolution of medical and Dental Sciences 2:10, pages 1425-1436.
Crossref
Jean Charchaflieh, Jiandong Wei, Georges Labaze, Yunfang Joan Hou, Benjamin Babarsh, Helen Stutz, Haekyung Lee, Samrat Worah & Ming Zhang. (2012) The Role of Complement System in Septic Shock. Clinical and Developmental Immunology 2012, pages 1-8.
Crossref
Jeffrey M. Halter, Lucio A. Pavone, Jay M. Steinberg, Louis A. Gatto, Joseph DiRocco, Steve Landas & Gary F. Nieman. (2006) CHEMICALLY MODIFIED TETRACYCLINE (COL-3) IMPROVES SURVIVAL IF GIVEN 12 BUT NOT 24 HOURS AFTER CECAL LIGATION AND PUNCTURE. Shock 26:6, pages 587-591.
Crossref
Shigeo Yamamura. (2003) Clinical application of artificial neural network (ANN) modeling to predict pharmacokinetic parameters of severely ill patients. Advanced Drug Delivery Reviews 55:9, pages 1233-1251.
Crossref
Fletcher B. TaylorJr,Jr,. (2001) Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: Examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants. Critical Care Medicine 29, pages S78-S89.
Crossref
G. Umberto Meduri. 2001. Evolving Concepts in Sepsis and Septic Shock. Evolving Concepts in Sepsis and Septic Shock 111 127 .
G. Umberto Meduri. 2000. Multiple Organ Failure. Multiple Organ Failure 514 523 .
G. U. Meduri. 1999. Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E. 693 710 .
G. Umberto Meduri & George P. Chrousos. (1998) Duration of Glucocorticoid Treatment and Outcome in Sepsis. Chest 114:2, pages 355-360.
Crossref
G. Umberto Meduri & Siva Kanangat. (1998) Glucocorticoid treatment of sepsis and acute respiratory distress syndrome. Critical Care Medicine 26:4, pages 630-633.
Crossref
G. Pindur. 1998. Antithrombin — Diagnostik und Therapie. Antithrombin — Diagnostik und Therapie 31 38 .
C. Erik Hack, Lucien A. Aarden & Lambertus G. Thus. 1997. Advances in Immunology Volume 66. Advances in Immunology Volume 66 101 195 .
H. Böhrer & P. P. Nawroth. 1997. Life-Threatening Coagulation Disorders in Critical Care Medicine. Life-Threatening Coagulation Disorders in Critical Care Medicine 3 40 .
J. N. Hoffmann, W. H. Hartl, R. Deppisch, E. Faist, M. Jochum & D. Inthorn. (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Medicine 22:12, pages 1360-1367.
Crossref
George W. Burke, Robert Cirocco, Ana Viciana, Phillip Ruiz, Michael Markou, Mustafa Allouch, Gaetano Ciancio, Rajender Reddy, Lennox Jeffers, Eugene Schiff, Jose Nery, Joshua Miller & Andreas G. Tzakis. (1996) EARLY GRAFT LOSS SECONDARY TO MASSIVE HEMORRHAGIC NECROSIS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION. Transplantation 61:9, pages 1370-1376.
Crossref
Hajime Nakae, Shigeatsu Endo, Katsuya Inada & Masao Yoshida. (1996) Chronological changes in the complement system in sepsis. Surgery Today 26:4, pages 225-229.
Crossref
H. Tomasdottir, J. P. Bengtson & A. Bengtsson. (2008) Neutrophil and macrophage activation and anaphylatoxin formation in orthotopic liver transplantation without the use of veno‐venous bypass. Acta Anaesthesiologica Scandinavica 40:2, pages 250-255.
Crossref
H. Böhrer & P. P. Nawroth. 1996. Lebensbedrohliche Gerinnungsstörungen in der Intensivmedizin. Lebensbedrohliche Gerinnungsstörungen in der Intensivmedizin 3 41 .
Johannes N. Hoffmann, Wolfgang H. Hartl, Reinhold Deppisch, Eugen Faist, Marianne Jochum & Dietrich Inthorn. (1995) Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney International 48:5, pages 1563-1570.
Crossref
Jiri Mayer, Roman Hajek, Jiri Vorlicek & Miroslav Tomiska. (1995) Sepsis and septic shock. Supportive Care in Cancer 3:2, pages 111-119.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.